TrustCore Financial Services’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.94K Hold
65
﹤0.01% 903
2022
Q3
$2K Hold
65
﹤0.01% 956
2022
Q2
$4K Hold
65
﹤0.01% 876
2022
Q1
$4K Hold
65
﹤0.01% 886
2021
Q4
$7K Hold
65
﹤0.01% 747
2021
Q3
$6K Hold
65
﹤0.01% 835
2021
Q2
$6K Buy
65
+20
+44% +$1.6K ﹤0.01% 816
2021
Q1
$4K Buy
45
+6
+15% +$619 ﹤0.01% 812
2020
Q4
$2K Buy
+39
New +$1.63K ﹤0.01% 842

Other funds holding FLGT

TrustCore Financial Services's FLGT Position: Q4 2022 in Review

TrustCore Financial Services held its Fulgent Genetics (FLGT) position steady in Q4 2022 at 65 shares worth $1.94K. The position accounts for ﹤0.01% of the portfolio, ranked #903.

TrustCore Financial Services first reported a position in FLGT in Q4 2020 and has held it in 9 quarters since. The position peaked at $7K in Q4 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • TrustCore Financial Services held 65 shares of Fulgent Genetics worth $1.94K as of Q4 2022.
  • TrustCore Financial Services left its Fulgent Genetics share count unchanged in Q4 2022.
  • Fulgent Genetics made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #903 holding.
  • TrustCore Financial Services first reported a position in Fulgent Genetics in Q4 2020 and has held it in 9 quarters since.
  • TrustCore Financial Services's Fulgent Genetics position peaked at $7K in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.